Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RUT058-60 Lavage in Abdominal Surgery
NCT02280395Phase 2Terminated
- Sponsor
- Pulmatrix, Inc.
- Start
- Oct 2014
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of RUT058-60 in surgical site infection (SSI) (2 arms), sponsored by Pulmatrix, Inc. Primary endpoint: Safety and tolerability determined by adverse events, clinical laboratory values, and wound site physical inspection at 28 Days. Started Oct 2014; status: terminated.
02
Drugs
RUT058-60
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT02280395.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02280395.